{"transactions":[{"id":831516,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Premium Priced Stock Appreciation Rights","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":17663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a Premium Priced Stock Appreciation Right (\"PPSAR\") granted under the 2017 Plan. The PPSAR exercise price per share is equal to 110% of the Fair Market Value (as defined in the 2017 Plan) of a share of common stock on the Grant Date. The PPSAR vests in three equal annual installments beginning March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. The PPSAR is payable in cash, shares of common stock, or a combination thereof, at the Issuer's discretion, in accordance with the 2017 Plan, as amended, and the applicable award agreement."}],"balance_after":17663,"derivative":{"exercise_price":15.6,"expiration_date":"2036-03-19","underlying":"Common Stock","underlying_shares":17663},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":831515,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":11194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the \"2017 Plan\"), and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":11194,"derivative":{"underlying":"Common Stock","underlying_shares":11194},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":831514,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":13097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the \"2017 Plan\"), and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":13097,"derivative":{"underlying":"Common Stock","underlying_shares":13097},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":839767,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":2658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":2659,"derivative":{"underlying":"Common Stock","underlying_shares":2658},"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839766,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":3774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":7550,"derivative":{"underlying":"Common Stock","underlying_shares":3774},"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839765,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":781,"price":14.2,"value":11090.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of 781 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026."}],"balance_after":24107,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839764,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":2658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":24888,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839763,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1449,"price":14.2,"value":20575.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,449 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":22230,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839762,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":1161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":23679,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839761,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":3774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":22518,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":849582,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2197},"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}},{"id":849581,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":639,"price":14.96,"value":9559.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 639 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026."}],"balance_after":18744,"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}},{"id":849580,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2197,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 528 shares purchased on May 14, 2025 and 616 shares purchased on November 14, 2025."}],"balance_after":19383,"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}}]}